INTRODUCTION
The small G protein Rap1 (Krev-1), a member of the Ras superfamily, has been brought to the forefront since the discovery that it regulates diverse cellular processes such as integrin activation and cell adhesion, cell spreading, cell polarity and cell-cell junction formation , , .
[1] [2] [3]
To gain more insights into these pathways, a variety of effector proteins that interact with active Rap1GTP-bound form has been identified. Among them, RAP1, which is enriched in lymphoid tissues, activates the integrin L 2, most likely by interacting with L integrin and
RIAM, which binds to different actin regulators, participates in an integrin activation complex that binds to and activates integrins . VAV1 β [5] and TIAM1 are localized by Rap1GTP to sites of cell spreading and serve as exchange factors for Rac . ARAP3 is a GTPase-activating [6] protein for RhoA and Arf6 that affects PDGF-induced lamellipodia formation . In dictyostelium, Phg2 promotes myosin II disassembly at [7] the front of chemotaxing cell facilitating filamentous-actin mediated leading edge protrusion . Afadin/AF6 participates in the maturation of [8] cell-cell junctions . [9] Krit1 (Krev Interaction Trapped gene) was identified in 1997 as a Rap1 partner in a yeast two-hydrid screen , but subsequent studies [10] did not confirm their interaction , leading to the conclusion that Krit1 is not a Rap1 partner . However, several pieces of evidence [11] [ 12] concerning a potential role of Krit1 in Rap1-regulated cellular processes prompted us to reconsider this question. First, it has recently been demonstrated that Rap1-dependent activation of integrins requires talin binding to the cytoplasmic tail of integrin . Talin is an essential β [13] integrin-activating protein that connects the cytoplasmic tail of integrins to the actin cytoskeleton . ICAP-1 (Integrin Cytoplasmic Domain β [14] Associated Protein) is a partner of the cytoplasmic tail of 1 integrin and it has been shown to compete with talin for binding to 1 integrin . β β [15] Consistently, on ICAP-1-null osteoblasts and fibroblasts, fibronectin receptors are in an active conformation and 1-dependent cell adhesion is β enhanced compared to that of wild-type cells , . On the opposite, overexpression of ICAP-1 reduces cell spreading and disorganizes [16] [17] focal adhesions . These results suggest that at resting state, 1 integrin is kept inactive through binding of ICAP-1 to its cytoplasmic tail.
[15] β ICAP-1 , suggesting that Krit1 could relieve the inhibitory effect of ICAP-1 on 1 integrin activation. The second piece of evidence [11] β concerns the existence of a human genetic disease linked to mutations in Krit1 gene. CCM1 (cerebral cavernous malformation 1) corresponds to brain capillaries malformations characterized by clusters of dilated thin-walled blood vessels . These lesions usually hemorrhage [19] resulting in seizures, focal neurological deficits or stroke. Ultrastructural studies show that tight junctions are absent between the endothelial cells in these lesions and that the surrounding basal lamina is hypertrophied . [20] Very little is known about the Krit1 protein and its subcellular localization. First, Krit1 C-terminus amino acid sequence bears homologies with FERM domains (present in band Four-point-one/Ezrin/Radixin/Moesin). FERM domains localize proteins to the plasma membrane, where they can interact with phosphoinositides and membrane proteins . The FERM domain of talin interacts with phosphatidylinositol 4, 5-P [21] 2 (PIP ) and with the cytoplasmic tail of integrins . Moreover, proteins with FERM domains usually exist in two conformational states: a 2 β [14] closed inactive conformation where the FERM domain is masked by another part of the protein and an open active conformation where the
FERM domain is unmasked. Cleavage, phosphorylation or (PIP ) binding are activation signals . Second, it has been reported that Krit1 2 [21] interacts with tubulin in BAEC and decorates microtubules all along their length . However, this interaction has been questioned because [22] the antibody used in this study recognized a protein of lower size on western blot. Another antibody has since identified a protein of the predicted size, but the primary location of Krit1 awaits elucidation . Since microtubules are known to regulate the dynamics of focal [39] adhesion assembly , , we readressed this important issue.
[23] [24] In this paper, we sought for the interaction of Krit1 
RESULTS

Krit1 contains a putative FERM domain and binds to PIP 2
Tri-dimensional structure of the FERM domain of the archetypal ERM proteins, ezrin, radixin and moesin, have been resolved by crystallography , , . They are composed of three sub-domains F1 to F3 arranged in a clover-shaped fashion ( ). F3 sub-domain [25] [26] [27] Fig . 1A resembles a PTB domain, a conserved structural fold that binds to protein NPxY motifs . Analysis of Krit1 sequence using Blast program [28] shows that the last 300 amino acid residues of Krit1 bear roughly 20 identity with F1, F2, F3 sub-domains of the typical ERM proteins (ezrin, % radixin, moesin, talin). Even though this is the lower limit for comparative modelling, we were able to generate models for Krit1 F1 and F2-F3 sub-domains structure based on the homology with radixin F1 in complex with IP3 and with talin F2 F3. ( ). These models displayed very stable secondary structures and energies throughout molecular dynamics simulations, strongly supporting the idea that Krit1 C-terminus folds as a FERM domain.
A functional feature of FERM domains is their capacity to interact with PIP on plasma membrane. In the radixin-IP3 co-crystal, IP3 binds 2 to a basic cleft located between F1 and F3 sub-domains and folded around a tryptophan present at the hydrophobic base of the cleft ( [26] Fig.  ) . Interestingly, on our model of the Krit1 FERM domain, basic residues are also found in the cleft between sub-domain F1 and F3 and the 1A tryptophan at the base of the pocket is conserved ( ), implying that Krit1 would have the structural features required for binding to Fig. 1B phospho-inositides on membranes. We therefore tested the ability of Krit1 to binding to PIP containing membranes. Krit1 was incubated with 2 artificial liposomes supplemented or not with 2 PIP at increasing NaCl concentrations. At 100 mM NaCl, 70 of Krit1 bound to PIP liposomes ( ). Moreover, increasing salt concentrations decreased Krit1 binding, highlighting the electrostatic status of this interaction (  Fig. 1C ). Intriguingly, in addition to its C-terminal FERM domain, Krit1 has a NPAY motif on its N-terminus that binds to ICAP-1 , . This [11] [18] peculiarity of Krit1 led us to ask whether this motif could interact with Krit1 F3 PTB-like sub-domain. To test this hypothesis, we separately expressed His-tagged N-terminus (1 to 207 aa) and GST-C-terminus (207-end), which we called Krit1-NTer and GST-HypoKrit1, respectively ( ). GST pull-down assays were performed by mixing these two fragments at a concentration of 100 nM each. Remarkably, Krit1-NTer Fig. 2A inserm-00322435, version 1 -3 Oct 2008 bound specifically to GST-HypoKrit1 and to GST-ICAP-1 used as a positive control, but it did not bind to GST alone ( ). To test Fig. 2B whether the NPAY motif is involved in this interaction, we mutated Asn192 and Tyr195 into alanines in Krit1-NTer ( ). Krit1-NTer Fig. 2A APAA mutant did not interact with GST-HypoKrit1 and interacted only very weakly with GST-ICAP-1 as previously reported ( ). [11] These results show that Krit1 C-terminal FERM domain interacts with Krit1 N-terminus in vitro, and that this interaction requires the ICAP-1 binding motif NPAY. They suggest that full-length Krit1 exists in a closed conformation with the N-terminus folded on the C-terminus and that ICAP-1 binding to the N-terminal part disrupts Krit1 N and C-termini interaction.
Krit1 interacts with Rap1 preferentially in its GTPS bound form
To answer the question of whether Krit1 is a Rap1 effector, i. e. whether Krit1 interacts preferentially with Rap1 in its GTP-bound form, we performed GST-pull down assays. Since we could not purify GST-full-length Krit1 because of its insolubility in E.Coli, we studied the binding of Rap1 to GST-HypoKrit1. We compared the binding of 1 M of Rap1 loaded with GDP or GTP S to 10 M of GST-HypoKrit1 by μ γ μ
GST pull-down experiments. Unless specified, all the experiments were performed with Rap1 A isoform. Rap1 binding to HypoKrit1 was specific, as no binding was observed to GST. Rap1GTP S bound twice more strongly to HypoKrit1 than did Rap1GDP, reflecting a higher γ affinity of active Rap1 for HypoKrit1 ( ). In the same assay conditions, H-Ras GTP S did not bind to HypoKrit1 ( ). This Therefore, this experiment shows that the three proteins form a ternary complex in vitro.
Rap1 binds equally to Krit1 opened and closed conformations and does not open Krit1
Next, we compared the binding of Rap1 to Krit1 closed and opened conformations. To do so, we measured by GST-pull down the binding by FLAG-pull-down experiment using FLAG-tagged Krit1. Addition of ICAP-1 together with Rap1 did not change Rap1 binding to Krit1 ( Fig.   ) . Therefore, Rap1 and ICAP-1 can bind independently to Krit1. All together, our results suggest that, unlike ICAP-1, Rap1 binding to the 5B C-terminal FERM domain does not induce the opening of Krit1 and that Rap1 binds as well on Krit1 closed and opened conformations (Fig. 5C ).
Krit1 interacts in vitro with microtubules via two sites present respectively on its N-and C-termini
It has previously been shown that Krit1 colocalizes with microtubules in BAEC . However, the antibody used in these studies [22] recognizes a 58 kDa protein on western blot which could correspond either to a shorter splice variant of Krit1 or to another protein. N-terminal part of the protein centered on residues 46 to 50 with high affinity for MT and a second site located on the F3 sub-domain with low affinity for MT.
Rap1 and ICAP-1 inhibit in vitro Krit1 binding to microtubules
Having shown that MT bind to the N-and C-termini of Krit1, we asked whether ICAP-1 or Rap1, which bind respectively to Krit1 N-and C-termini, could modulate Krit1 interaction with MT. Thus, we measured the binding of 40 pmoles of Krit1 to MT in presence of 200 pmoles of Rap1GTP S or GST-ICAP-1. Rap1GTP S alone was not recruited to MT and less than 10 of GST-ICAP-1 bound to MT ( ).
Remarkably, both Rap1GTP S and GST-ICAP-1 inhibited Krit1 binding to MT whereas GST alone had no effect ( ). Similar inhibition 
YFP-Krit1 co-localizes with CFP-labelled microtubules in transfected BHK cells and is delocalized from microtubules by activated Rap1
To confirm our in vitro results in a cellular context, we co-expressed Krit1 fused to YFP together with CFP-tubulin in BHK cells. While YFP-ARNO signal, used as a negative control, was diffuse in the cytosol, YFP-Krit1 signal was superimposable to the CFP-labelled microtubules signal indicating that YFP-Krit1 was localized along microtubules from MTOC to periphery. Co-expression of activated mutant of Rap1, HA-Rap1V12, flattened the cells which became spread and displayed numerous membrane spikes, a phenotype also observed with HA-Rap1V12 alone (data not shown). Remarkably, YFP-Krit1 was no longer co-localized with CFP-labelled microtubules in Rap1V12 expressing BHK cells. Thus, these experiments support our in vitro observations that Krit1 binds to microtubules and that this binding is inhibited by Rap1GTP .
Rap1 enhances HypoKrit1 binding to asolectin vesicles
An other feature of Krit1 is its capacity to bind to phospholipids. We wondered whether Rap1, which binds to Krit1 FERM domain, could modulate Krit1 association with membranes. Remarkably, when 3 M of Rap1GTP S were added to 0.5 M GST-HypoKrit1, we observed a 
DISCUSSION
In this paper, we confirm that Krit1 specifically interacts in vitro with Rap1 and preferentially with active Rap1 (GTP-bound form), the criteria for Krit1 being a bona-fide effector of Rap1. We show for the first time that Krit1 exists in a closed conformation in which its " " N-terminus interacts with its C-terminus. ICAP-1 binding to the N-terminal NPAY motif disrupts this interaction, whereas Rap1 binding to the C-terminal FERM domain does not. Moreover, we show that Krit1, Rap1 and ICAP-1 can form a ternary complex in vitro.
Krit1 binds in vitro to microtubules via two sites on its N and C-termini. Remarkably, Rap1 and ICAP-1 inhibit in vitro Krit1 binding to microtubules. In transfected BHK cells, YFP-Krit1 localizes along CFP-labelled microtubules and is delocalized from microtubules by co-expression of activated Rap1V12. Finally we show that Krit1 binds to phospholipids on membranes and that Rap1 enhances this binding.
Krit1 is an effector of Rap1
Our interaction between the two proteins . This discrepancy might be related to the methods applied. These authors used in vitro translation of [11] Rap1 and Krit1. The amount of proteins produced might not be sufficient for co-immunoprecipitation, since micromolar concentrations of the two proteins were necessary in our hands to observe a complex. Consistently, an interaction of low affinity (Kd 4.7 M) was found between = μ
Krit1 and Rap1B, a very close homolog of Rap 1A . We did not detect any interaction of H-Ras with Krit1 as previously reported , , [29] [10] [30] . Thus, it appears that Krit1 is a specific effector of Rap1, suggesting that it is involved in a Ras-independent, Rap1-dependent pathway. [29] Even though it has been proposed that Rap1 may bind to Krit1 F1 sub-domain because this sub-domain bears homology with a computerized model of Ras Binding Domain (RBD) , the absence of interaction between HypoKrit1 C and Rap1 rather suggests that Rap1 interacts with Further mutagenesis studies will be necessary to map precisely the site [32] [33] for Rap1 interaction on Krit1 FERM domain.
Krit1, like other FERM proteins, adopts closed and opened conformations and binds to PIP2
The molecular modeling of the last 300 amino acid residues of Krit1 that we generated corroborates the existence of a FERM domain at the lipid with a basic cleft present between F1 and F3 sub-domains. Consistently, we show that Krit1 binds to PIP . Interestingly, several basic 2 residues are exposed to the F1 F3 cleft on the Krit1 FERM model that we generated. Mutagenesis analyses of these residues will help to -determine whether the binding site of the polar head of PIP on Krit1 is similar to that of radixin. . Consistently, we demonstrate the interaction of the N-terminus of Krit1 with its C-terminus, both parts being produced separately. Cis or [21] trans interaction between these two domains are equally possible and would lead to either an intramolecular folding in a closed conformation or an intermolecular folding in an anti-parallel homodimer like talin. Furthermore, we have shown that the N-terminal NPAY motif is involved in the interaction, which suggests that the PTB-like F3 sub-domain of the FERM is the C-terminal counterpart. As such, in the dormant form of moesin, F3 sub-domain is masked by the N-terminal extended actin binding tail domain . Moreover, we show that ICAP-1 binding disrupts [27] Krit1 N and C-termini interaction. This interaction, as well as its disruption by ICAP-1, could be verified on the full-length protein by fluorescence resonance energy transfer (FRET) of Krit1 fused to YFP and CFP at its extremities. This could represent a crucial mechanism of regulation of Krit1 activity. Indeed, both NPAY motif and PTB-like F3 sub-domain are binding sites for other partners, such as ICAP-1,
phospholipids and yet unknown partners most likely trans-membrane or peri-membrane proteins. Masking of these two sites may prevent Krit1 to interact with other proteins until it is delivered to its target (s). It has been shown that Krit1 interacts with the CCM2 gene product malcavernin, a PTB domain protein, in the context of a Rac/MEKK3/MKK3 signalling complex which activates p38 MAPK kinase . [35] Krit1-CCM2 interaction does not involve the NPAY motif and a ternary complex can form between Krit1, CCM2 and ICAP-1. It is possible that Krit1, through its interaction with different partners on the plasma membrane, participates in several but linked signalling pathways involved in angiogenesis .
[35]
Rap1 and ICAP-1 regulate Krit1 localization to microtubules and membranes
Among the FERM family members, ERM proteins and talin provide a regulated linkage between membrane proteins and the cortical actin cytoskeleton. No actin-binding site has been reported on Krit1. Consistently, purified Krit1 does not interact with in vitro polymerized actin (Eric Macia, personal communication) nor does YFP-Krit1 localize in cells to phalloidin-labelled F-actin (data not shown). Instead, we confirm the previous report that Krit1 is a microtubule-associated protein by showing that it co-localizes with microtubules in cells and that it [22] interacts directly with in vitro polymerized microtubules. Moreover, our results show that Krit1 binds to MT through two sites: one basic site in the N-terminal part of the protein located on residues 46 to 51 with high affinity for MT and a second on the C-terminus in the F3 sub-domain with low affinity for MT. The N-terminal basic motif has also been described as a functional nuclear localization sequence , suggesting that [39] it could be involved in the shuttling of Krit1 between the microtubules and the nucleus. Remarkably, the contribution of these two sites to the binding to MT is additive ( ). Since we show that the N-terminus of Krit1 interacts with the C-terminus, it is most likely that these two MT. Two hypotheses can be proposed concerning the mechanism of this inhibition. The first one is that they directly mask the surface that binds to MT. Indeed our results show that MT and Rap1 both bind to the last fifty residues of Krit1. It is not so clear for the basic stretch which lies between residues 46 to 51. ICAP-1 binds further on the primary sequence on the NPAY motif. It is possible however that these two 191 194 sites are actually close in the folded protein. The second hypothesis is that ICAP-1 binding provokes structural changes of the basic site that lead to a decrease of its affinity for MT. Nevertheless, the fact that ICAP-1 is a more potent inhibitor than Rap1 correlates well with, for one part, its stronger binding to Krit1 at the micromolar concentrations used in these experiments and, for the second part, with the higher contribution to the binding to MT of the basic stretch than the C-terminal site.
At the cell periphery, Rap1 shuttles between recycling endosomes and the plasma membrane, its GTP form being localized at the plasma membrane . Interestingly, we show that Rap1GTP S stimulates HypoKrit1 binding to artificial membranes. HypoKrit1 is not recruited to [36] effector. Indeed, RAPL also localizes on MT in endothelial cells and directly binds to in vitro polymerized MT . In wound healing assays, [37] RAPL localizes on MT oriented toward the leading edge, an area where Rap1 is highly activated and its interaction with Rap1 is required for directional migration . Moreover, co-expression of Rap1V12 also induces dissociation of RAPL from MT . In lymphocytes, RAPL [37] [ 37] moves dynamically from the peri-nuclear region to the leading edge upon chemokine stimulation and activated Rap1 triggers the association of RAPL with L 2 leading to the redistribution of this integrin to the immunological synapse . In addition to integrin activation, Rap1 induces
cell polarization and facilitates cell migration. Expression of activated Rap1 polarizes lymphocytes, generating a leading edge at the front and a uropod at the back. It also stimulates lymphocyte endothelium transmigration and directional migration of endothelial cells . Therefore, [38] [ 37] delivery of Rap1 effectors to focal adhesions by the MT network might participate in the polarized activation of integrins. In line, targeting of MT in close vicinity of adhesion foci on the plasma membrane has been reported , as well as regulation of the turn-over of focal adhesions [39] by MT , . Based on our results, we propose a model of regulation of Krit1 binding to MT and plasma membrane; in the cell, Krit1
[23] [24] would be transported in its closed conformation along MT toward the plasma membrane. When reaching the membrane, Krit1 would detach from MT and be captured by activated Rap1 and ICAP-1 on the plasma membrane ( ). In the absence of ICAP-1, Rap1GTP would bind to Fig. 9 Krit1 favouring its detachment from the MT and its binding to the plasma membrane without, however, opening it. This complex could serve as a stock for a rapid delivery of Krit1 to its target sites on the plasma membrane.
An important breakthrough in unraveling the Rap1-dependent pathway in integrin activation has been achieved recently by Han et al . [13] Their work demonstrates that Rap1 promotes talin binding to the cytoplasmic tail of 3 and 1 integrins. They show that Rap1 induces the β β formation of an integrin activation complex which contains talin and RIAM, a Rap1 effector. RIAM is known to bind to profilin and Ena/VASP suggesting that it could participate in actin network formation at the level of focal adhesion .
[5] [13] Concerning activation of 1 integrin per se, i. e. its switch to high affinity conformation, our present data and Han s lead us to hypothesize
that this Rap1-dependent activation complex could contain Krit1. Its binding to ICAP-1 would displace ICAP-1 from its inhibitory site on 1 β integrin, therefore allowing talin binding and subsequent 1 conformational changes. Further work is in progress to determine whether Krit1 is β targeted by the microtubule network to focal adhesions and whether Rap1, RIAM and ICAP-1 regulate this localization. Furthermore, functional studies will investigate the role of Krit1 on cell adhesion to determine whether Krit1 is involved in the Rap1-dependent integrin activation pathway. substitutions of KRKK and introduction of a stop codon at aa 686 were produced using the QuikChange mutagenesis kit (Stratagene, Amsterdam, The Netherlands). pMT2-HA-Rap1A and pMT2-HA-Rap1AV12 were kindly provided by J. L. Bos (University Medical Center, Utrecht, The Netherlands). C-terminal-deleted (1 167) Rap1A was sub-cloned into pET16b (Novagen). ICAP-1 was sub-cloned in pGEX-2T.
MATERIAL AND METHODS
Plasmid
-
Purification of recombinant proteins
The expression of Krit1 and Krit1 KRKK/AAAA in BL21(DE3)codon cells (Stratagene) was induced at an optical Escherichia. coli + density (OD600) of 0.8 with 0.2 mM isopropyl--D thio-galactopyranoside and grown for an additional 16 h at 18 C. His-tagged Rap1, β°H is-tagged Krit1-Nter WT and APAA, GST-HypoKrit1, GST-HypoKrit1 C, Krit1-Nter-GST, and GST-ICAP-1 were produced in Δ Escherichia.
B121 gold (Stratagene) induced with 0.2 mM IPTG at OD 0.8 for 3 h at 28 C. Purifications were performed according to manufacturer coli°i nstructions using the nickel-charged resin Ni-NTA (Qiagen, Courtaboeuf, France) for His-Tagged proteins or Glutathione sepharose 4B (GE Healthcare Europe GmbH, Orsay, France) for GST fusions. Purified His-tagged Krit1 WT and KRKK/AAAA were dialyzed and concentrated against 50 mM phosphate buffer pH 8.0, 120 mM NaCl, 10 glycerol, DTT 1 mM. All other proteins were dialyzed and concentrated in 20 % mM Tris-HCl pH 7.5, 120 mM NaCl, 1 mM MgCl , and 10 glycerol and supplemented with 20 M GDP for His-tagged Rap1. A fraction of 2 % μ purified GST-ICAP-1 was cleaved by thrombin according to manufacturer instructions (GE Healthcare). Protein concentration was determined by SDS-PAGE and fluorometric analysis of Sypro Orange (Amresco, Interchim, Montlucon, France ) stained gel using a Fuji LAS3000 fluorescence imaging system.
Preloading of Rap1 with GDP or GTPS
Purified Rap1 was incubated for 45 min at 30 C in 50 mM Tris-HCl pH 7.5, 120 mM NaCl, 1 mM MgCl , 2 mM EDTA, 10 glycerol and°2 % 2 mM GTP S or GDP (Roche Diagnostics). The loaded nucleotide was stabilized in the nucleotide site by addition of 5 mM MgCl . 
Microtubule sedimentation experiments
Tubulin purification and polymer preparation 
Immunofluorescence and cell microscopy
BHK cells were co-transfected with pEYFP-Krit1 and pECFP-tubulin with or without pMT2-HA-Rap1VI2. Twenty-four hours after transfection, cells were fixed in 4 PFA for 20 minutes and processed for immunofluorescence analysis as already described .
% [41] HA-Rap1V12 was labelled with 3F10 anti-HA monoclonal antibody (Roche Diagnostics). Confocal microscopy analysis was carried out using a Leica TCS-SP5 microscope (Leica Microsystemes SAS, Rueil-Malmaison, France).
Asolectin vesicles and liposome sedimentation experiments
Asolectin vesicles and liposomes preparation
Asolectin (Sigma Aldrich) vesicles were prepared by the reverse phase method and sucrose-loaded liposomes (plasma membrane mix: [42] 40 PC, 15 PE, 20 cholesterol, 25 PS, 0.2 NBD-PE; 2 mM lipids) were prepared by the extrusion method . Lipids in chloroform % % % % % [43] were purchased from Avanti Polar Lipids except for egg PC (Sigma Aldrich) and NBD-PE (Molecular Probes Europe, Leiden, The Netherlands)
Sedimentation experiments
Proteins were incubated for 20 min at 25 C with sucrose-loaded liposomes or asolectin vesicles in 20 mM Tris-HCl pH 8.0, 120 mM NaCl,°I mM MgCl , 10 glycerol, 1 mM DTT and were centrifuged for 20 min at 400000g at 20 C. The percentage of proteins in the supernatant and 2 %°p ellet was determined by fluorometric analysis of the Sypro-Orange stained gel using fluorescence imaging.
Modelling of Krit1 FERM domain
The Psi-Blast web tools were used to obtain alignments of Krit1 last 300 residues with different template sequences. The structure of [44] radixin (pdb entry; 1GC6) was used as template for Fl FERM domain and that of talin (pdb entry: 1Y19) for F2 and F3 FERM domains. The alignments were improved manually, taking into account the predicted secondary structure of Krit1 and the secondary structures of talin and radixin. One hundred models of Fl, F2 and F3 domains were constructed separately by comparative modelling with the MODELLER 7
program . The best model was retained for each FERM domain and the side chains were repositioned in optimized conformations, using [45] SCWRL and SCit web server . The models were finally subjected to energy minimization. The stability of these models was assayed by [46] [ 47] molecular dynamics simulations using the Gromos 96 force field implemented in GROMACS version 3.2.1 . Since there is a good [48] conservation of the spatial arrangement of F1-F2-F3 among the cristallized FERM domains, the three modelized Krit1 subdomains were manually positioned according to the arrangement of radixin FERM domain. Structures were visualized with Pymol (Delano Scientific LLC, USA)
Fig. 1
Krit1 contains a putative FERM domain and binds to PIP 2 (A) Radixin-IP3 co-crystal structure. IP3 is in yellow, basic residues of F1 (K53, K60, K63, K64) and F3 (R273, R275, R279) domains are in red. by Sypro Orange staining of the gel. Rap1 binding was visualized by western blot using His-tag antibody. These results were reproduced three times. intermolecular folding between two molecules of Krit1 is however not excluded.
Fig. 6
Krit1 interacts directly with microtubules in vitro via two sites in its N-and C-termini and Rap1 and ICAP-1 inhibits this interaction In each experiment, 40 pmoles of Krit1 were incubated in the absence or presence of taxol-stabilized MT polymerized in vitro from 150 pmoles of purified tubulin and centrifuged on sucrose gradient. Supernatant (S) and pellet (P) were analyzed by SDS-PAGE and the percentage of Krit1 
Fig 9
Model of regulation of Krit1 binding to microtubules and plasma membrane In the cell, Krit1 would be transported in its closed conformation along the microtubules toward the plasma membrane. When reaching the membrane, Krit1 would detach from MT and be captured by activated Rap1 and ICAP-1 on the plasma membrane.
